Curaleaf Holdings, Inc. (CURLF)
For informational purposes only. Not financial advice. Analysis by Sedat Aydin, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.
Curaleaf Holdings, Inc. (CURLF) with AI Score 53/100 (Hold). Curaleaf Holdings, Inc. is a leading cannabis operator in the United States, involved in the production and sale of cannabis through retail and wholesale channels. Market cap: 0, Sector: Healthcare.
Last analyzed: Mar 16, 2026Curaleaf Holdings, Inc. (CURLF) Healthcare & Pipeline Overview
Curaleaf Holdings, Inc. is a vertically integrated cannabis company in the U.S., operating 134 dispensaries and 26 cultivation sites across 22 states. It offers a range of cannabis products and services, including retail, wholesale, and professional services, positioning itself as a key player in the expanding cannabis market.
Investment Thesis
Curaleaf Holdings, Inc. presents a compelling investment case based on its strong market position and growth potential within the expanding U.S. cannabis industry. As of March 16, 2026, key value drivers include the company's extensive retail footprint with 134 dispensaries and 26 cultivation sites, its vertically integrated operations, and its diverse product portfolio. The company's negative P/E ratio of -15.23 and negative ROE of -22.0% indicate potential for improvement as the company scales and optimizes operations. Growth catalysts include the ongoing legalization of cannabis in additional states, increasing consumer acceptance, and expansion of its product offerings. Potential risks include regulatory uncertainties, competition, and the company's high debt-to-equity ratio of 123.42.
Based on FMP financials and quantitative analysis
Key Highlights
- Operates 134 dispensaries and 26 cultivation sites across 22 states as of June 16, 2022, demonstrating a significant retail and production footprint.
- Gross Margin of 49.8% indicates strong pricing power and efficient cost management in its operations.
- Market Cap of $1.83B reflects its position as a leading cannabis operator in the United States.
- Debt-to-Equity ratio of 123.42 suggests a highly leveraged capital structure, which could pose risks and opportunities.
- Beta of 1.45 indicates higher volatility compared to the overall market, potentially offering higher returns but also greater risk.
Competitors & Peers
Strengths
- Extensive retail network and geographic reach.
- Vertically integrated operations.
- Diverse product portfolio.
- Strong brand recognition.
Weaknesses
- High debt-to-equity ratio.
- Negative profitability metrics (P/E, ROE).
- Reliance on regulatory approvals.
- Exposure to fluctuating cannabis prices.
Catalysts
- Ongoing: Continued state-level legalization of cannabis for medical and recreational use.
- Upcoming: Potential federal cannabis reform, such as banking access or decriminalization.
- Ongoing: Expansion of retail footprint through new dispensary openings.
- Upcoming: Launch of new and innovative cannabis products.
- Ongoing: Strategic acquisitions to expand market presence.
Risks
- Potential: Regulatory uncertainties and changes in cannabis laws.
- Ongoing: Intense competition from other cannabis operators.
- Ongoing: Fluctuations in cannabis prices and supply chain disruptions.
- Potential: Difficulty in accessing traditional banking and financial services.
- Potential: Negative public perception and social stigma associated with cannabis.
Growth Opportunities
- Expansion into New States: As more states legalize cannabis for medical or recreational use, Curaleaf has the opportunity to expand its retail and cultivation operations into these new markets. This geographic expansion can drive significant revenue growth and increase its market share. The timeline for this growth is dependent on the pace of legalization in various states, but represents a substantial long-term opportunity.
- Product Innovation and Development: Curaleaf can drive growth by introducing new and innovative cannabis products to meet evolving consumer preferences. This includes developing new formulations, delivery methods, and product categories, such as edibles, concentrates, and topicals. The company can also focus on developing products with specific health and wellness benefits, targeting a broader customer base. The timeline for product development is ongoing, with new products expected to launch regularly.
- Strategic Acquisitions: Curaleaf can pursue strategic acquisitions to expand its market presence, acquire new technologies, or enter new product categories. Acquisitions can provide access to new markets, customer bases, and intellectual property, accelerating growth and enhancing its competitive position. The timing of acquisitions is opportunistic, depending on market conditions and available targets.
- Increased Retail Footprint: Curaleaf can continue to expand its retail footprint by opening new dispensaries in existing and new markets. This will increase its brand visibility, improve customer access, and drive sales growth. The company can also focus on optimizing its existing retail operations to improve efficiency and profitability. The timeline for retail expansion is ongoing, with new dispensaries planned for strategic locations.
- Development of Branded Products: Curaleaf can strengthen its brand recognition and customer loyalty by developing and marketing its own branded products. This includes creating a portfolio of high-quality cannabis products with distinct branding and marketing strategies. Branded products can command premium pricing and generate higher margins. The timeline for brand development is ongoing, with a focus on building brand equity and customer loyalty.
Opportunities
- Expansion into new states with legalization.
- Product innovation and development.
- Strategic acquisitions.
- Growth in the CBD market.
Threats
- Regulatory uncertainties and changes.
- Intense competition from other cannabis operators.
- Fluctuations in cannabis prices.
- Potential for federal legalization to disrupt the market.
Competitive Advantages
- Extensive retail network with 134 dispensaries provides a significant competitive advantage.
- Vertically integrated operations ensure quality control and cost efficiency.
- Strong brand recognition and customer loyalty.
- Intellectual property and proprietary cultivation techniques.
About CURLF
Founded in 2010 and headquartered in Wakefield, Massachusetts, Curaleaf Holdings, Inc. has grown to become a significant player in the United States cannabis industry. The company operates through two segments: Cannabis Operations and Non-Cannabis Operations. The Cannabis Operations segment focuses on the cultivation, processing, and sale of cannabis products through its retail dispensaries and wholesale channels. These products include flowers, pre-rolls, concentrates, edibles, and hemp-based CBD products. The Non-Cannabis Operations segment provides a range of professional services to other cannabis licensees, including cultivation, processing, and retail know-how, along with back-office administration, intellectual property licensing, real estate leasing, and lending facilities. Curaleaf's extensive network includes 134 dispensaries and 26 cultivation sites across 22 states as of June 16, 2022, reflecting its broad geographic reach and commitment to serving both medical and adult-use cannabis markets. The company's vertically integrated business model allows it to control the entire value chain, from cultivation to retail, ensuring product quality and consistency.
What They Do
- Cultivates and processes cannabis.
- Manufactures cannabis products including flowers, pre-rolls, concentrates, edibles, and topicals.
- Operates retail dispensaries for direct sales to consumers.
- Engages in wholesale distribution of cannabis products.
- Provides professional services to other cannabis licensees.
- Develops and markets hemp-based CBD products.
Business Model
- Vertically integrated operations, controlling the entire value chain from cultivation to retail.
- Generates revenue through the sale of cannabis products in its retail dispensaries.
- Generates revenue through wholesale distribution to other retailers.
- Provides professional services to other cannabis licensees for a fee.
Industry Context
Curaleaf operates in the rapidly evolving cannabis industry, which is experiencing significant growth due to increasing legalization and changing consumer attitudes. The U.S. cannabis market is highly fragmented and competitive, with numerous players vying for market share. Curaleaf's vertically integrated model and extensive retail network provide a competitive advantage. The industry faces regulatory hurdles and varying state laws, creating both challenges and opportunities for companies like Curaleaf. As of 2026-03-16, the market is trending towards consolidation and increased product innovation.
Key Customers
- Medical cannabis patients seeking therapeutic relief.
- Adult-use cannabis consumers for recreational purposes.
- Wholesale customers, including other retailers and dispensaries.
- Other cannabis licensees seeking professional services.
Financials
Chart & Info
Curaleaf Holdings, Inc. (CURLF) stock price: Price data unavailable
Latest News
-
Washington Post Reported President Trump Expected To Announce A Medicare Pilot Program To Reimburse Patients' CBD Treatments
benzinga · Dec 18, 2025
-
'Trump to sign executive order reclassifying marijuana: Officials' -ABC Report
benzinga · Dec 17, 2025
-
Hess Midstream Signs $100M Repurchase That Includes Class B Units Of Hess Midstream Operations From chevron Affiliate And Hess Midstream's Class A Shares From Public
benzinga · Aug 5, 2025
-
'GOP-Led Congressional Panel Demands Investigation On Biden's Marijuana Rescheduling Process, Citing 'Deviations' And 'Mental Health Hazards'' -Marijuana Moment Report
benzinga · Jun 10, 2025
Analyst Consensus
Consensus Rating
Aggregated Buy/Hold/Sell recommendations from Benzinga, Yahoo Finance, and Finnhub for CURLF.
Price Targets
Wall Street price target analysis for CURLF.
MoonshotScore
What does this score mean?
The MoonshotScore rates CURLF's growth potential on a scale of 0-100 across multiple factors including innovation, market disruption, financial health, and momentum.
Latest News
Washington Post Reported President Trump Expected To Announce A Medicare Pilot Program To Reimburse Patients' CBD Treatments
'Trump to sign executive order reclassifying marijuana: Officials' -ABC Report
Hess Midstream Signs $100M Repurchase That Includes Class B Units Of Hess Midstream Operations From chevron Affiliate And Hess Midstream's Class A Shares From Public
'GOP-Led Congressional Panel Demands Investigation On Biden's Marijuana Rescheduling Process, Citing 'Deviations' And 'Mental Health Hazards'' -Marijuana Moment Report
Leadership: Boris Alexis Jordan
CEO
Boris Jordan is a prominent figure in the cannabis industry, known for his extensive experience in international finance and emerging markets. Prior to his role at Curaleaf, Jordan held leadership positions at Renaissance Capital, a leading investment bank in Russia. He has a strong background in investment management and has been instrumental in driving Curaleaf's growth and expansion.
Track Record: Under Boris Jordan's leadership, Curaleaf has grown to become one of the largest cannabis companies in the United States. He has overseen significant acquisitions, strategic partnerships, and expansion into new markets. Jordan has also focused on building a strong management team and fostering a culture of innovation and compliance.
CURLF OTC Market Information
The OTC Other tier, where Curaleaf trades, represents the lowest tier of over-the-counter (OTC) markets. Unlike stocks listed on major exchanges like the NYSE or NASDAQ, companies on the OTC Other tier often have limited financial disclosure requirements and may not meet the listing standards of the larger exchanges. This tier typically includes companies with limited operating history, penny stocks, and those facing financial difficulties. Investing in companies on the OTC Other tier carries higher risks due to the lack of regulatory oversight and transparency compared to listed companies.
- OTC Tier: OTC Other
- Disclosure Status: Unknown
- Limited financial disclosure increases information asymmetry.
- Lower trading volume can lead to price volatility.
- Higher bid-ask spreads can increase transaction costs.
- Potential for delisting or trading suspensions.
- Increased risk of fraud or manipulation.
- Verify the company's regulatory filings and financial statements.
- Assess the company's management team and track record.
- Evaluate the company's business model and competitive landscape.
- Analyze the company's capital structure and debt levels.
- Monitor trading volume and price volatility.
- Consult with a financial advisor.
- Understand the risks associated with OTC investing.
- Established operations with multiple dispensaries and cultivation sites.
- Presence in multiple states with legal cannabis markets.
- Experienced management team with a track record in the industry.
- Focus on compliance and regulatory adherence.
- Positive media coverage and industry recognition.
Common Questions About CURLF
What does Curaleaf Holdings, Inc. do?
Curaleaf Holdings, Inc. is a leading cannabis company that cultivates, processes, and sells cannabis products through its retail dispensaries and wholesale channels. The company operates in two segments: Cannabis Operations and Non-Cannabis Operations. The Cannabis Operations segment focuses on the production and sale of cannabis products, while the Non-Cannabis Operations segment provides professional services to other cannabis licensees. Curaleaf's vertically integrated business model allows it to control the entire value chain, from cultivation to retail, ensuring product quality and consistency.
What do analysts say about CURLF stock?
Analyst coverage of CURLF is pending. Investors should independently evaluate the company's financials, market position, and growth prospects. Key valuation metrics to consider include revenue growth, gross margin, and profitability. Growth considerations include the pace of state-level legalization, the company's ability to expand its retail footprint, and its success in developing and marketing new products. Investors should also be aware of the risks associated with investing in the cannabis industry, including regulatory uncertainties and competition.
What are the main risks for CURLF?
The main risks for Curaleaf Holdings, Inc. include regulatory uncertainties and changes in cannabis laws, intense competition from other cannabis operators, fluctuations in cannabis prices and supply chain disruptions, difficulty in accessing traditional banking and financial services, and negative public perception and social stigma associated with cannabis. The company's high debt-to-equity ratio also poses a financial risk. Investors should carefully consider these risks before investing in CURLF.
What are the key factors to evaluate for CURLF?
Curaleaf Holdings, Inc. (CURLF) currently holds an AI score of 53/100, indicating moderate score. Key strength: Extensive retail network and geographic reach.. Primary risk to monitor: Potential: Regulatory uncertainties and changes in cannabis laws.. This is not financial advice.
How frequently does CURLF data refresh on this page?
CURLF prices update in real time during U.S. market hours (9:30 AM-4:00 PM ET, weekdays). Fundamentals refresh after quarterly or annual filings. Analyst ratings and AI insights update daily. News is aggregated continuously from financial sources.
What has driven CURLF's recent stock price performance?
Recent price movement in Curaleaf Holdings, Inc. (CURLF) can be influenced by earnings results, analyst revisions, sector rotation, and broader market sentiment. Notable catalyst: Extensive retail network and geographic reach.. Check the News and Technical Analysis tabs for the latest drivers. Past performance does not predict future results.
Should investors consider CURLF overvalued or undervalued right now?
Determining whether Curaleaf Holdings, Inc. (CURLF) is overvalued or undervalued requires examining multiple metrics. Compare valuation ratios (P/E, P/S, EV/EBITDA) against sector peers for a comprehensive view.
What research should beginners do before buying CURLF?
Before investing in Curaleaf Holdings, Inc. (CURLF), research these four areas: (1) the company's revenue model and competitive position (see Company Overview), (2) financial health through revenue growth, margins, and cash flow (see MoonshotScore), (3) what Wall Street analysts recommend and their price targets (see Analyst tab), and (4) specific risk factors that could impact the stock (see Risk Factors section).
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.
- Financial data as of 2026-03-16. OTC market data may have limited availability.